As an industry, biopharma actually fares pretty well when it comes to taxes. Among profitable companies, biotech and pharma have some of t...

Santa’s sleigh may be loaded to the brim with gifts come Christmas Eve but it was Deals of the Week that carried a heavy load during the ...

More options are always better, right? Obviously, that’s a “yes” when it comes to building our dream Tesla Model S. But big biopharma is ...

Industry business-development executives rang in the start of what should be a most interesting New Year's (the score's been set ...

It's time for the IN VIVO Blog's Fourth Annual Deal of the Year! competition. This year we're presenting awards in three categor...

Finally. The months of waiting are over. (No, we aren’t talking about the Phillies’ attempt to dominate in the National League (it's ...

It's time for the IN VIVO Blog's Third Annual Deal of the Year! competition. This year we're presenting awards in three categori...